All News

Two Framework Programme 6 (FP6) schemes specifically devised to promote the development of the European Research Area failed to deliver, according to a new report.

Roche has granted Russian start-up Viriom Ltd a licence to develop and commercialise potential novel treatments for HIV/AIDS patients in Russia, Ukraine, Belarus and Kazakhstan.

The commercial imperative is undermining basic research and threatening the university ethos according to an independent body, says a new report.

The Alsace BioValley cluster has launched SHIP-In, a project to develop induced pluripotent stem cells for use in drug discovery.

A £37 million Bioscience Campus is to be set up at GlaxoSmithKline’s site at Stevenage, UK, with funding from the government, GlaxoSmithKline, and other partners.

The UK Technology Strategy Board (TSB) will invest £39.5 million across six calls in the next six months, in areas from regenerative medicine to low carbon housing.

Microsoft and Tilburg University in the Netherlands have entered into a four-year agreement in which Microsoft will support the research of the Tilburg Law and Economics Centre.

While the US needs a quality lift; Europe needs political leadership and new governance, says Bruno van Pottelsberghe of the Bruegel think tank.